Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
15/04/2026 02:51
April 15 (Reuters) - Noxopharm Ltd NOX.AX: NOXOPHARM APPOINTS DR OLIVIER LACZKA AS NEW CEO Further company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer